3.69

3.40% -0.13

Achieve Life Sciences Inc (ACHV)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACHV? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.82

Offen:

$3.8

24-Stunden-Volumen:

462.43K

Relative Volume:

3.84

Marktkapitalisierung:

$126.90M

Einnahmen:

Nettoeinkommen (Verlust:

$-32.94M

KGV:

-1.1865

EPS:

-3.11

Netto-Cashflow:

$-24.95M

1W Leistung:

-10.00%

1M Leistung:

-14.29%

6M Leistung:

-21.32%

1J Leistung:

+8.85%

1-Tages-Spanne:

$3.60

$3.96

1-Wochen-Bereich:

$3.60

$4.205

52-Wochen-Spanne:

$3.2001

$5.59

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Firmenname

Achieve Life Sciences Inc

Sektor

Healthcare (1176)

Branche

Biotechnology (673)

Telefon

425-686-1500

Adresse

22722 29TH DR. SE, SEATTLE, BC

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-12-07

Neueste SEC-Einreichungen

ACHV's Discussions on Twitter

Vergleichen Sie ACHV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ACHV Achieve Life Sciences Inc	3.69	126.90M	0	-32.94M	-24.95M	-1.11
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-14	Eingeleitet	Rodman & Renshaw	Buy
2024-09-27	Eingeleitet	Raymond James	Strong Buy
2023-05-10	Bestätigt	Maxim Group	Buy
2021-06-23	Eingeleitet	Oppenheimer	Outperform

Achieve Life Sciences Inc Aktie (ACHV) Neueste Nachrichten

Dec 21, 2024

Achieve Life Sciences, Inc. (NASDAQ:ACHV) down to US$131m market cap, but institutional owners may not be as affected after a year of 0.5% returns - Simply Wall St

Dec 21, 2024

Dec 20, 2024

Franklin Resources Inc. Sells 2,181,025 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat

Dec 20, 2024

Charles Schwab Investment Management Inc. Sells 6,324 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Dec 20, 2024

Dec 13, 2024

Playing the Long Game To Achieve Financial Success - Yahoo Finance

Dec 13, 2024

Molecule AI wins award at BioSpectrum Asia Excellence Awards 2024 - European Pharmaceutical Manufacturer

Dec 13, 2024

Dec 12, 2024

Puerto Rico air cargo community scoops CEIV Pharma certification - Air Cargo News

Dec 12, 2024

Axtria Leads Frost & Sullivan's First Pharmaceutical Commercialization Solutions and Services Industry Radar Report - PR Newswire

Dec 12, 2024

Dec 10, 2024

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Dec 10, 2024

Dec 09, 2024

GFO-X Announces ABN AMRO Clearing, IMC, Standard Chartered Bank and Virtu Financial as Strategic Partners Ahead of Launch in Q1 2025 - The Manila Times

Dec 09, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Dec 09, 2024

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer - GlobeNewswire

Dec 09, 2024

Achieve Life Sciences, Inc. Appoints Mark Oki as Chief Financial Officer - Marketscreener.com

Dec 09, 2024

Achieve Life Sciences Taps Biotech Veteran Mark Oki as New CFO to Lead Financial Strategy - StockTitan

Dec 09, 2024

Dec 04, 2024

Achieve Life Sciences shares rise on positive FDA meeting outcome By Investing.com - Investing.com Canada

Dec 04, 2024

Gene Therapy Market Trends in Market Growth: Size, Demand, - openPR

Dec 04, 2024

Dec 03, 2024

Kane Biotech Announces $3,000,000 Private Placement Offering - The Manila Times

Dec 03, 2024

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA - GlobeNewswire

Dec 03, 2024

Achieve Life Sciences Gets FDA Green Light for Landmark Vaping Cessation Drug Trial | ACHV Stock News - StockTitan

Dec 03, 2024

Smoking Cessation and Nicotine Addiction Market Growth Anticipated by 2034 | Axsome Therapeutics, Achieve Life Sciences, NFL Biosciences SAS, expected to boost the market - The Globe and Mail

Dec 03, 2024

Smoking Cessation and Nicotine Addiction Market Growth - openPR

Dec 03, 2024

Dec 01, 2024

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Down 9.6% in November - MarketBeat

Dec 01, 2024

Nov 29, 2024

Vaping risks: Study reveals new health concerns - WBBJ-TV

Nov 29, 2024

Nov 28, 2024

Gene Therapy Market Size, Share, Trends, and Analysis 2024-2032 - openPR

Nov 28, 2024

Nov 27, 2024

Science Says 3 Strategies Will Help You Achieve Your Big Goals and Live Your Best Life - Inc.

Nov 27, 2024

Nov 20, 2024

Drug Discovery Outsourcing Services Market to Achieve a Superb - openPR

Nov 20, 2024

Nov 19, 2024

Clovertex Awarded AWS Life Sciences Competency, Solidifying Leadership in Cloud-Based Solutions for Life Sciences - IT News Online

Nov 19, 2024

Nov 18, 2024

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives $14.80 Average Price Target from Analysts - Defense World

Nov 18, 2024

HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World

Nov 18, 2024

Nov 16, 2024

Achieve Life Sciences (NASDAQ:ACHV) Raised to “Strong-Buy” at RODMAN&RENSHAW - Defense World

Nov 16, 2024

FitLife Brands, Inc. Announces Financial Results for Quarter Ended September 30, 2024 - Defense World

Nov 16, 2024

Nov 15, 2024

Brokerages Set Achieve Life Sciences, Inc. (NASDAQ:ACHV) Target Price at $14.80 - MarketBeat

Nov 15, 2024

Achieve Life Sciences (NASDAQ:ACHV) Upgraded by RODMAN&RENSHAW to "Strong-Buy" Rating - MarketBeat

Nov 15, 2024

Nov 14, 2024

Achieve Life Sciences stock rated Buy ahead of NDA submission By Investing.com - Investing.com UK

Nov 14, 2024

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewswire

Nov 14, 2024

Achieve Life Sciences to Present at Jefferies, Piper Sandler Healthcare Conferences | ACHV Stock News - StockTitan

Nov 14, 2024

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Nov 14, 2024

Rodman & Renshaw Begins Coverage on Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat

Nov 14, 2024

FY2024 Earnings Estimate for ACHV Issued By Zacks Small Cap - Defense World

Nov 14, 2024

Nov 13, 2024

Research Analysts Set Expectations for ACHV FY2024 Earnings - MarketBeat

Nov 13, 2024

Nov 12, 2024

How to achieve a successful drug launch in the first year - MM+M Online

Nov 12, 2024

Nov 11, 2024

ACHV: Commercialization in Focus - Zacks Small Cap Research

Nov 11, 2024

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Nov 09, 2024

How to Take Advantage of moves in (ACHV) - Stock Traders Daily

Nov 09, 2024

Achieve qtrly loss per share $0.90‍ - Reuters

Nov 09, 2024

Nov 08, 2024